BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 33272691)

  • 1. Laboratory quality assessment of candidate gene panel testing for acute myeloid leukaemia: a joint ALLG / RCPAQAP initiative.
    Corboy G; Othman J; Lee L; Wei A; Ivey A; Blombery P; Agarwal R; Fong C; Brown A; Scott H; Grove C; Louw A; Enjeti A; Iland H; Paul C; Bohlander S; Kakadia P; Horan M; Stevenson W
    Pathology; 2021 Jun; 53(4):487-492. PubMed ID: 33272691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variant Classification Concordance using the ACMG-AMP Variant Interpretation Guidelines across Nine Genomic Implementation Research Studies.
    Amendola LM; Muenzen K; Biesecker LG; Bowling KM; Cooper GM; Dorschner MO; Driscoll C; Foreman AKM; Golden-Grant K; Greally JM; Hindorff L; Kanavy D; Jobanputra V; Johnston JJ; Kenny EE; McNulty S; Murali P; Ou J; Powell BC; Rehm HL; Rolf B; Roman TS; Van Ziffle J; Guha S; Abhyankar A; Crosslin D; Venner E; Yuan B; Zouk H; ; Jarvik GP
    Am J Hum Genet; 2020 Nov; 107(5):932-941. PubMed ID: 33108757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Full Blood Count - Internal QC Protocol: a review by the Royal College of Pathologists of Australasia Quality Assurance Programs (RCPAQAP) Pty Ltd - Haematology.
    Sioufi J; Badrick T; Sinclair L; Marsden K
    Int J Lab Hematol; 2017 Feb; 39(1):84-94. PubMed ID: 27997738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Networking for advanced molecular diagnosis in acute myeloid leukemia patients is possible: the PETHEMA NGS-AML project.
    Sargas C; Ayala R; Chillón MC; Larráyoz MJ; Carrillo-Cruz E; Bilbao C; Yébenes-Ramírez M; Llop M; Rapado I; García-Sanz R; Vázquez I; Soria E; Florido-Ortega Y; Janusz K; Botella C; Serrano J; Martínez-Cuadrón D; Bergua J; Amigo ML; Martínez-Sánchez P; Tormo M; Bernal T; Herrera-Puente P; García R; Algarra L; Sayas MJ; Costilla-Barriga L; Pérez-Santolalla E; Marchante I; Lavilla-Rubira E; Noriega V; Alonso-Domínguez JM; Sanz MÁ; Sánchez-Garcia J; Gómez-Casares MT; Pérez-Simón JA; Calasanz MJ; González-Díaz M; Martínez-López J; Barragán E; Montesinos P
    Haematologica; 2021 Dec; 106(12):3079-3089. PubMed ID: 33179471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Observations from a national sample exchange program for molecular haematology testing.
    Gould C; McBean M; Thompson E; Lickiss J; Tiong IS; Westerman D; Blombery P
    Pathology; 2024 Jun; 56(4):540-547. PubMed ID: 38413254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perspective on how to approach molecular diagnostics in acute myeloid leukemia and myelodysplastic syndromes in the era of next-generation sequencing.
    Kohlmann A; Bacher U; Schnittger S; Haferlach T
    Leuk Lymphoma; 2014 Aug; 55(8):1725-34. PubMed ID: 24144312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Papanicolaou Staining and Processing Troubleshooting Exercise Using Digital Pathology: Peer Comparison in an External Quality Assurance Setting.
    Pagliuso J; Greaves J; Lau A; Badrick T
    Acta Cytol; 2020; 64(6):597-606. PubMed ID: 32829336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The first GHEP-ISFG collaborative exercise on forensic applications of massively parallel sequencing.
    Barrio PA; García Ó; Phillips C; Prieto L; Gusmão L; Fernández C; Casals F; Freitas JM; González-Albo MDC; Martín P; Mosquera A; Navarro-Vera I; Paredes M; Pérez JA; Pinzón A; Rasal R; Ruiz-Ramírez J; Trindade BR; Alonso A
    Forensic Sci Int Genet; 2020 Nov; 49():102391. PubMed ID: 32957016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid On-Site Evaluation Technical Exercise Using Digital Pathology: Peer Comparison in an External Quality Assurance Setting.
    Greaves J; Pagliuso J; Ross J; Badrick T
    Acta Cytol; 2022; 66(3):235-243. PubMed ID: 35235926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium.
    Amendola LM; Jarvik GP; Leo MC; McLaughlin HM; Akkari Y; Amaral MD; Berg JS; Biswas S; Bowling KM; Conlin LK; Cooper GM; Dorschner MO; Dulik MC; Ghazani AA; Ghosh R; Green RC; Hart R; Horton C; Johnston JJ; Lebo MS; Milosavljevic A; Ou J; Pak CM; Patel RY; Punj S; Richards CS; Salama J; Strande NT; Yang Y; Plon SE; Biesecker LG; Rehm HL
    Am J Hum Genet; 2016 Jun; 98(6):1067-1076. PubMed ID: 27181684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triphenotypic acute leukaemia: the contribution of multimodality laboratory diagnostic techniques.
    Leitinger E; Kuzich JA; Juneja S
    Pathology; 2021 Aug; 53(5):678-680. PubMed ID: 33461800
    [No Abstract]   [Full Text] [Related]  

  • 12. Diagnosing and following adult patients with acute myeloid leukaemia in the genomic age.
    Roug AS; Hansen MC; Nederby L; Hokland P
    Br J Haematol; 2014 Oct; 167(2):162-76. PubMed ID: 25130287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proposal for a classification of acute myeloid leukaemia based on plastic-embedded bone marrow biopsy sections.
    Islam A
    Leuk Res; 1993 May; 17(5):421-7. PubMed ID: 8501969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole-exome sequencing reveals the spectrum of gene mutations and the clonal evolution patterns in paediatric acute myeloid leukaemia.
    Shiba N; Yoshida K; Shiraishi Y; Okuno Y; Yamato G; Hara Y; Nagata Y; Chiba K; Tanaka H; Terui K; Kato M; Park MJ; Ohki K; Shimada A; Takita J; Tomizawa D; Kudo K; Arakawa H; Adachi S; Taga T; Tawa A; Ito E; Horibe K; Sanada M; Miyano S; Ogawa S; Hayashi Y
    Br J Haematol; 2016 Nov; 175(3):476-489. PubMed ID: 27470916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation of panel testing by next-generation sequencing (NGS) for gene mutations in myeloid neoplasms.
    Au CH; Wa A; Ho DN; Chan TL; Ma ES
    Diagn Pathol; 2016 Jan; 11():11. PubMed ID: 26796102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular-based classification of acute myeloid leukemia and its role in directing rational therapy: personalized medicine for profoundly promiscuous proliferations.
    Wertheim GB; Hexner E; Bagg A
    Mol Diagn Ther; 2012 Dec; 16(6):357-69. PubMed ID: 23184342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurable residual disease monitoring for patients with acute myeloid leukemia following hematopoietic cell transplantation using error corrected hybrid capture next generation sequencing.
    Balagopal V; Hantel A; Kadri S; Steinhardt G; Zhen CJ; Kang W; Wanjari P; Ritterhouse LL; Stock W; Segal JP
    PLoS One; 2019; 14(10):e0224097. PubMed ID: 31658273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemistry in Acute Myeloid Leukemia.
    Cruise MW
    Methods Mol Biol; 2017; 1633():33-49. PubMed ID: 28735479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. External hematology quality assurance initiative in Asia. Asian Quality Assurance Survey (AQuAS)Program.
    Lee KN; Yoon SY; Cho HI; Tatsumi N; Maramba T
    Lab Hematol; 2004; 10(3):152-7. PubMed ID: 15529428
    [No Abstract]   [Full Text] [Related]  

  • 20. The external quality assessment schemes in Thailand.
    Opartkiattikul N; Bejrachandra S
    Rinsho Byori; 2002 Feb; 50(2):121-5. PubMed ID: 11925846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.